Grown Rogue International Inc.

GRIN

CA39986R1064

Pharmaceuticals

Delayed Canadian Securities Exchange Other stock markets 01:48:15 2024-05-22 pm EDT			5-day change	1st Jan Change
1.12 ^CAD	+5.66%		+10.89%	+194.74%

Apr. 30	Grown Rogue International Inc. Reports Earnings Results for the Two Months Ended December 31, 2023	CI
Mar. 05	Grown Rogue Announces Entry Into Illinois	MT

Grown Rogue International Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023

June 19, 2023 at 05:05 pm EDT

Grown Rogue International Inc. reported earnings results for the second quarter and six months ended April 30, 2023. For the second quarter, the company reported revenue was USD 6 million compared to USD 4.7 million a year ago. Net income was USD 0.412846 million compared to USD 1.02 million a year ago.
For the six months, revenue was USD 10.54 million compared to USD 8.43 million a year ago. Net income was USD 1.34 million compared to USD 0.613353 million a year ago.

Latest news about Grown Rogue International Inc.

Grown Rogue International Inc. Reports Earnings Results for the Two Months Ended December 31, 2023	Apr. 30	CI
Grown Rogue Announces Entry Into Illinois	Mar. 05	MT
EBC PARTNERS, LLC and Grown Rogue International Inc. entered into a definitive agreement to acquire CannEquality LLC.	Mar. 04	CI
Grown Rogue International Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	Feb. 28	CI
Grown Rogue International Inc. Announces Change of Financial Year End	Jan. 29	CI
Grown Rogue Augmenting New Jersey Presence With Retail Investment	Jan. 17	MT
Grown Rogue Expands Presence in New Jersey With Retail Investment; Down 2.7%	Jan. 17	MT
Grown Rogue International Inc. Forms Grown Rogue Retail Ventures LLC	Jan. 17	CI
Grown Rogue Augments Management Team With New Additions	Jan. 04	MT
Grown Rogue's Fiscal Q4 Loss After Tax Widens, Sales Revenue Rises	Dec. 19	MT
Grown Rogue International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	23-09-26	CI
Goodness Growth Holdings, Inc. Enters into First Amendment to Consulting Agreement with Grown Rogue Unlimited ULC	23-09-25	CI
Grown Rogue Closed Second and Final Tranche of Convertible Debenture Financing For Total Proceeds of US$6 Million	23-08-18	MT
Grown Rogue International Inc. announced that it has received $5 million in funding from Mindset Capital	23-07-12	CI
Grown Rogue Announces Proposed Convertible Debenture Financing of up to US$5 Million	23-07-04	MT
Grown Rogue International Inc. announced that it expects to receive $5 million in funding	23-07-03	CI
Grown Rogue Reports Second Quarter 2023 Results	23-06-20	MT
Grown Rogue International Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	23-06-19	CI
Goodness Growth Holdings and Grown Rogue International Announce Strategic Advisory Agreement	23-05-25	CI
Grown Rogue International Reports First Quarter 2023 Results	23-03-28	MT
Earnings Flash (GRUSF) GROWN ROGUE INTERNATIONAL Posts Q1 Revenue $4.5M	23-03-28	MT
Grown Rogue International Inc. Auditor Raises 'Going Concern' Doubt	23-02-27	CI
Grown Rogue International Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	23-02-27	CI
Grown Rogue International Inc. Increases Oregon Sungrown Capacity	23-02-21	CI
Grown Rogue International Closes US$2.0 Million Convertible Debenture Financing	22-12-05	MT

Chart Grown Rogue International Inc.

Duration

Period

More charts

Company Profile

Grown Rogue International Inc. is a Canada-based craft cannabis company focused on providing customers with flower and flower-derived products. The Company's geographical segments include Oregon, Michigan and Services. The Company, through its subsidiary, Grown Rogue Gardens, LLC, operates four cultivation facilities in Oregon, comprising approximately 90,000 square feet of cultivation area, that service the Oregon recreational marijuana market: two outdoor, sungrown farms called Foothill and Ross Lane, and two indoor facilities called Rossanley and Airport. Its subsidiary, Canopy Management, LLC, operates a Golden Harvests facility that produces indoor flower through controlled environment agriculture (CEA), with 14 individual flowering rooms in operation. The Company provides consulting services in various operating markets, including Maryland and Minnesota. It produces a range of cultivars for consumers, which are traditionally classified as indicas, sativas and hybrids.

Sector

Pharmaceuticals

Calendar

2024-06-23 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
GROWN ROGUE INTERNATIONAL INC.	+194.74%	162M
DONG-E-E-JIAO CO.,LTD.	+38.28%	6.29B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-16.91%	4.42B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+5.14%	3.3B
TASLY PHARMACEUTICAL GROUP CO., LTD	-14.63%	3.05B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-4.12%	2.47B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+42.14%	1.94B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-10.63%	1.66B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-2.71%	1.61B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.26%	1.54B

Alternative Medicine